MiniMed (MMED) Accumulated Expenses (2025 - 2026)

MiniMed (MMED) posted Accumulated Expenses of $126.0 million for Q3 2026, down 22.7% quarter-over-quarter from $163.0 million in Q2 2026.

Analysis

MiniMed (MMED) Accumulated Expenses (2025 - 2026) Analysis & Trends

MiniMed (MMED) has 2 years of Accumulated Expenses data on file, last reported at $126.0 million in Q3 2026.

For the quarter ending Q3 2026, Accumulated Expenses changed N/A year-over-year to $126.0 million; the trailing twelve-month figure through Jul 2026 stood at $126.0 million (changed N/A YoY), and the FY2026 full-year result was $163.0 million, down 10.44% from the prior year.
Accumulated Expenses was $126.0 million for Q3 2026 at MiniMed, down from $163.0 million in the prior quarter.
In the past five years, Accumulated Expenses ranged from a high of $184.0 million in Q1 2026 to a low of $126.0 million in Q3 2026.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	187.42 Bn	182.47 Bn	7.27 Bn
2	Intuitive Surgical	129.78 Bn	124.69 Bn	1.96 Bn
3	Medtronic	120.53 Bn	112.33 Bn	6.34 Bn
4	Stryker	116.28 Bn	112.80 Bn	4.50 Bn
5	Boston Scientific	69.29 Bn	68.99 Bn	3.85 Bn
6	Edwards Lifesciences	51.83 Bn	47.68 Bn	1.35 Bn
7	Alcon	34.36 Bn	32.91 Bn	1.68 Bn
8	Dexcom	33.17 Bn	31.23 Bn	830.00 Mn
9	Steris	21.90 Bn	21.43 Bn	684.20 Mn
10	MiniMed	6.55 Bn	6.34 Bn	465.00 Mn

Historic Data

Download Data